Charles Rhyee
Stock Analyst at TD Cowen
(1.09)
# 2,976
Out of 4,667 analysts
49
Total ratings
31.25%
Success rate
-12.13%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $187.90 | +20.81% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $19.15 | +30.55% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $9.00 | -11.11% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $203.67 | +39.93% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $326.09 | +14.08% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $210.63 | -8.84% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.31 | +271.23% | 7 | May 16, 2024 | |
| CAH Cardinal Health | Maintains: Market Perform | $88 → $90 | $120.34 | -25.21% | 1 | Aug 16, 2023 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $3.16 | +58.23% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.84 | +537.76% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $194.38 | +29.13% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $4.41 | +1,169.84% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.78 | +1,694.87% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $11.31 | +342.09% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $621.14 | -41.88% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.83 | +176,949.18% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $22.23 | +57.44% | 1 | Feb 13, 2018 |
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $187.90
Upside: +20.81%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $19.15
Upside: +30.55%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $9.00
Upside: -11.11%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $203.67
Upside: +39.93%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $326.09
Upside: +14.08%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $210.63
Upside: -8.84%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.31
Upside: +271.23%
Cardinal Health
Aug 16, 2023
Maintains: Market Perform
Price Target: $88 → $90
Current: $120.34
Upside: -25.21%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.16
Upside: +58.23%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.84
Upside: +537.76%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $194.38
Upside: +29.13%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $4.41
Upside: +1,169.84%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.78
Upside: +1,694.87%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $11.31
Upside: +342.09%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $621.14
Upside: -41.88%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.83
Upside: +176,949.18%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $22.23
Upside: +57.44%